glp 1 and multiple sclerosis You might know them as Ozempic, Wegovy, Mounjaro, Zepbound. GLP-1 receptor agonists are best known for managing diabetes and promoting weight loss, but researchers are discovering a wide spectrum of effective Full article: Targeting metabolic dysfunction

"The cost difference is notable given that they are the same drug," Day points out

This increase in WBC (of approximately 200 cells/microL vs placebo, in four pooled placebo-controlled clinical studies, with a mean baseline WBC count of approximately 6600 cells/microL) is not considered to be clinically relevant

Someone with both type 2 diabetes and obesity may be prescribed it for weight, but it is not a swap for a diabetes medicine All of these are prescription-only medicines in India, approved and regulated by the Central Drugs Standard Control Organisation, or CDSCO [10]

Anyone considering non-pharmaceutical sources must understand the risks

Please note that this is not medical advice

[DOI] [PMC free article] [PubMed] [Google Scholar] 76.Gullo F., Ceriani M., DAloia A., Wanke E., Constanti A., Costa B., Lecchi M